India

COVID-19 Coronavirus Pandemic – Latest Media Coverage

Messenger RNA

RNA that is read by the ribosome to produce a protein

Messenger RNA ▸ Facts ▸ Comments ▸ News ▸ Videos

Messenger RNA: RNA that is read by the ribosome to produce a protein

In molecular biology, messenger ribonucleic acid (mRNA) is a single-stranded molecule of RNA that corresponds to the genetic sequence of a gene, and is read by a ribosome in the process of synthesizing a protein.

0 shares	Share Tweet Save Post Send


Russian Claims Big Cancer Breakthrough: New Anti-Cancer Vaccine To Shatter America in 2025 In a groundbreaking development, Russia has announced a new anti-cancer vaccine that could revolutionize cancer treatment worldwide. Set to be released by early 2025, the vaccine, developed through a.. Credit: Oneindia Duration: 03:02Published on December 18, 2024

You Might Like

Covaxin had much lower adverse effects and overall favourable short-term safety profile in adolescents: Study Bharat Biotech’s indigenously developed Covid-19 vaccine Covaxin was overall found to have “much lower” AEFI (adverse effects following immunisation) rates in adolescents with a favourable.. IndiaTimes - Published on May 16, 2024
UK patients test 'gamechanger' bespoke jab for melanoma The world's first personalised mRNA cancer jab for melanoma is being tested in British patients. Sky News - Published on April 26, 2024
Gennova sees uptick in its Omicron-specific Covid booster Pune-based Gennova Biopharmaceuticals witnessed demand for its Omicron-specific Covid-19 vaccine, Gemcovac-OM, due to the recent surge in cases. Gemcovac-OM is India's first mRNA-based vaccine approved.. IndiaTimes - Published on December 28, 2023

COVID vaccine scientists win Nobel Prize in medicine The Nobel Prize in medicine has been awarded to two scientists for their research which led to the development of effective mRNA vaccines against COVID-19. Sky News - Published on October 2, 2023
Ocugen-Bharat Biotech Covid vaccine Covaxin meets main goals in US trial Ocugen Inc said on Monday the Covid-19 vaccine developed by its Indian partner Bharat Biotech International Ltd met the main goals of a trial in the United States. The vaccine, sold under brand name.. IndiaTimes - Published on January 9, 2023
Cancer drug trial using COVID vaccine technology shows 'highly encouraging' results The same mRNA technology used in COVID vaccines can significantly increase the survival of patients with an aggressive form of skin cancer, according to new results. Sky News - Published on December 13, 2022